Nakamoto, Inc. (NAKA)
9.66
+0.55
(+6.04%)
USD |
NASDAQ |
Oct 02, 16:00
9.67
+0.01
(+0.10%)
After-Hours: 20:00
Nakamoto Enterprise Value : 318.50M for Oct. 2, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| October 02, 2026 | 318.50M |
| October 01, 2026 | 308.65M |
| September 30, 2026 | 314.92M |
| September 29, 2026 | 320.29M |
| September 28, 2026 | 319.57M |
| September 25, 2026 | 324.40M |
| September 24, 2026 | 320.29M |
| September 23, 2026 | 310.18M |
| September 22, 2026 | 322.25M |
| September 21, 2026 | 325.48M |
| September 18, 2026 | 309.73M |
| September 17, 2026 | 297.74M |
| September 16, 2026 | 292.37M |
| September 15, 2026 | 284.85M |
| September 14, 2026 | 292.55M |
| September 11, 2026 | 292.19M |
| September 10, 2026 | 284.50M |
| September 09, 2026 | 288.43M |
| September 08, 2026 | 287.90M |
| September 04, 2026 | 291.12M |
| September 03, 2026 | 294.34M |
| September 02, 2026 | 283.06M |
| September 01, 2026 | 271.79M |
| August 31, 2026 | 279.66M |
| August 28, 2026 | 278.77M |
| Date | Value |
|---|---|
| August 27, 2026 | 283.96M |
| August 26, 2026 | 269.82M |
| August 25, 2026 | 273.76M |
| August 24, 2026 | 274.48M |
| August 21, 2026 | 271.97M |
| August 20, 2026 | 258.37M |
| August 19, 2026 | 254.08M |
| August 18, 2026 | 235.29M |
| August 17, 2026 | 235.64M |
| August 14, 2026 | 233.85M |
| August 13, 2026 | 236.00M |
| August 12, 2026 | 234.03M |
| August 11, 2026 | 235.11M |
| August 10, 2026 | 235.82M |
| August 07, 2026 | 234.75M |
| August 06, 2026 | 234.21M |
| August 05, 2026 | 232.42M |
| August 04, 2026 | 236.36M |
| August 03, 2026 | 232.42M |
| July 31, 2026 | 230.63M |
| July 30, 2026 | 234.21M |
| July 29, 2026 | 222.22M |
| July 28, 2026 | 226.52M |
| July 27, 2026 | 229.56M |
| July 24, 2026 | 232.78M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Astrana Health, Inc. | 2.112B |
| Agilon Health, Inc. | 1.188B |
| Starling Oncology, Inc. | 701.36M |
| American Oncology Network, Inc. | -- |
| Regional Health Properties, Inc. | 61.16M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -131.20M |
| Revenue (Quarterly) | 35.87M |
| Total Expenses (Quarterly) | 167.07M |
| EPS Diluted (Quarterly) | -6.650 |
| Gross Profit Margin (Quarterly) | 24.31% |
| Profit Margin (Quarterly) | -365.8% |
| Earnings Yield | -369.4% |
| Normalized Earnings Yield | -138.26 |